GC12690
Alisertib
Also listed as MLN8237 (Alisertib)
Alisertib (MLN8237), as an investigational, orally available, selective aurora A kinase inhibitor, is usually used for the treatment of solid tumors and hematologic malignancies
ChemicalCAS1028486-01-2MW518.92FormulaC27H20ClFN4O4
- CAS number
- 1028486-01-2
- Molecular weight
- 518.92
- Formula
- C27H20ClFN4O4
- Solubility
- ≥ 25·9 mg/mL in DMSO
- InChIKey
- ZLHFILGSQDJULK-UHFFFAOYSA-N
- Catalogue number
- GC12690
- Brand
- GLPBIO
Computed properties PubChem CID 24771867 · XLogP 5 · TPSA 106 Ų · H-bond donors 2
- XLogP
- 5
- TPSA
- 106 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 6
- Heavy atoms
- 37
SMILES COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC
Computed descriptors from PubChem (CID 24771867), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il